Journal
ENVIRONMENTAL TOXICOLOGY
Volume 36, Issue 5, Pages 764-772Publisher
WILEY
DOI: 10.1002/tox.23078
Keywords
apoptosis; Genistein; human leukemia cancer HL‐ 60 cells; L‐ asparaginase; mitochondria dysfunction
Categories
Funding
- China medical University [CMU107-ASIA-17]
- Ministry of Science and Technology of Taiwan, Taiwan [MOST 107-2320-B-039-058]
Ask authors/readers for more resources
The combination treatment of GEN and Asp shows a greater anti-leukemia activity on human leukemia HL-60 cells compared to GEN or Asp treatment alone. Suggestions that this combination may enhance the efficacy of Asp in inducing apoptosis in HL-60 cells.
Genistein (GEN) has been shown to induce apoptotic cell death in various human cancer cells. L-asparaginase (Asp), a clinical drug for leukemia, has been shown to induce cell apoptosis in leukemia cells. No available information concerning GEN combined with Asp increased the cell apoptosis compared to GEN or Asp treatment alone. The objective of this study is to evaluate the anti-leukemia activity of GEN combined with Asp on human leukemia HL-60 cells in vitro. The cell viability, the distribution of cell cycle, apoptotic cell death, and the level of Delta psi(m) were examined by flow cytometric assay. The expressions of apoptosis-associated proteins were measured by western blotting. GEN combined with Asp revealed a more significant decrease in total viable cells and induced a higher percentage of G2/M phase arrest, DNA damage, and cell apoptosis than that of GEN or Asp treatment only in HL-60 cells. Furthermore, the combined treatments (GEN and Asp) showed a higher decrease in the level of Delta psi(m) than that of GEN or Asp treatment only. These results indicated that GEN combined with Asp induced mitochondria dysfunction by disrupting the mitochondrial membrane potential. The results from western blotting demonstrated that the treatment of GEN combined with Asp showed a higher increase in the levels of Bax and Bak (pro-apoptotic proteins) and an active form of caspase-3 and a higher decrease in Bcl-2 (anti-apoptotic protein) than that of GEN or Asp treatment alone. GEN significantly enhances the efficiency of Asp on cytotoxic effects (the induction of apoptosis) in HL-60 cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available